and biomarkers have not been concomitantly studied, previously, in the same patient group. The aim of this study is to assess the relationship and diagnostic accuracy of 4 RVEDD was defined as maximal short-axis dimension in the basal one third seen on right ventricle focused apical four chamber view. 4 Paradoxical ventricular septal motion was visually assessed for ventricular septal curvature, looking for a D shaped pattern in systole and diastole. TRJV was measured using continuous-wave Doppler across tricuspid valve. All the echocardiograms were performed by a single qualified operator who was blinded to clinical diagnosis, NT-proBNP and CTPA of the patients.
Echocardiogram

Computed tomography pulmonary angiography
CTPA was obtained from SIEMENS SOMATOM Definition AS, a single source 128 slice CT scanner. Right ventricle diameter was measured from inner wall to inner wall in the widest point, usually seen in basal third of right ventricle, on transverse section of reconstructed four chamber image showing the tricuspid valve at its widest. 17 [ 1 1 6 _ T D $ D I F F ] So also left ventricular diameter measured when mitral valve was at its widest. 17 The RV/LV diameter ratio was calculated. Ventricular septal bowing was subjectively judged as being present or absent.
Qanadli index
Extent of pulmonary vascular obstruction was graded using Qanadli index, a CTPA clot burden score, described by Qanadli et al. All the CTPA were assessed by a single qualified radiologist who was blinded to clinical data, echocardiogram and NT-proBNP levels of the patient. The study design was observational and did not interfere with therapeutic decisions. The protocol of this study was approved by the Institutional ethics Committee. All participating patients gave their informed consent. 
Results
A total of fifty-six patients were screened for acute PE and thirty-six were diagnosed to have acute PE. Six patients were excluded as 4 patients had renal dysfunction, 1 had left ventricular dysfunction and 1 had lung fibrosis secondary to pulmonary tuberculosis. Baseline characteristics of the study population are displayed in Table 1 . The patient's age ranged from 21 [ 1 3 3 _ T D $ D I F F ] to 76 years with mean age of 41.20 AE 12.98 years. Twenty four (80%) patients were males and 6 (20%) were females. Dyspnea (100%) was the most common symptom followed by chest pain (33.3%). Risk factors were dyslipidemia (43.3%), smoking (30%), immobilization due to recent trauma or surgery (26.7%), cancer (6.7%), hypertension (13.3%), diabetes (10%), stroke Ten patients (33.3%) were thrombolysed with streptokinase of whom two patients were thrombolysed ([ 1 3 8 _ T D $ D I F F ] primary thrombolysis) at admission due to systemic hypotension. All patients were treated with heparin. Nine patients had complicated in hospital course of whom 2 patients (6.7%) died (Table 2 ). Eight patients (26.7%) were thrombolysed (secondary thrombolysis) after deterioration during hospital stay. There was need for mechanical ventilation in 2 patients (6.7%) and inotropic support in 2 patients (6.7%). All these 9 patients had RVD.
Prognostic parameters of patients with and without adverse events are displayed in Table 3 . 
Echocardiography
There was no statistically significant difference of RV/LV ratio, RVEDD[ 1 4 2 _ T D $ D I F F ] , and TRJV, measured at admission, among patients with and without adverse events ([ 1 4 3 _ T D $ D I F F ] p = 0.38, p = 0.27, and p = 0.36, respectively). There was no adverse event in patients without RVD. ROC analysis of RVEDD and RV/LV ratio on echocardiography in predicting adverse events is displayed in Table 4 . 
Table 2
Combined adverse events in study population.
Combined 
AUC[ 6 2 _ T D $ D I F F ] , area under curve; PPV, positive predictive value; NPV[ 6 3 _ T D $ D I F F ] , negative predictive value; NT-proBNP[ 6 4 _ T D $ D I F F ] , N-terminal pro-brain natriuretic peptide; RV[ 6 5 _ T D $ D I F F ] , right ventricle; LV, left ventricle; CT, computed tomography; RVEDD[ 6 6 _ T D $ D I F F ]
, right ventricular end diastolic diameter. 
[ ( F i g . _ 1 ) T D $ F I G ]
Discussion
In this prospective study we assessed the prognostic values of Acute pressure overload and failure of right ventricle is a critical event in pathophysiology of acute PE. The diagnosis of RVD in acute PE is of utmost importance because RVD is associated with mortality. 1, 2, 19, 20 In our study all adverse events occurred in patients with RVD and secondary thrombolysis was required only in patients with RVD. 1,2 All the patients without RVD had uncomplicated hospital course similar to other studies. On ROC analysis NT-proBNP had good sensitivity and negative predictive value for patients without adverse events (100% and 100%) and modest specificity and positive predictive value for those with adverse events (38.1% and 40.9% respectively). NTproBNP is an effective tool to identify those without adverse events than those with adverse events. Our results corroborate with those of other published studies that have demonstrated a lower rate of in-hospital complications and better short-term prognosis in PE patients with low NT-proBNP levels. [ 1 7 6 _ T D $ D I F F ] Its role in risk stratification in these patients is debated. We found that Qanadli index is greater in patients with adverse events and RVD. Qanadli index predicts patients at low risk of adverse events with good negative predictive value but positive predictive value for adverse events is modest. Contrary to our findings some studies 29, 30, 32, 33 [ 1 7 8 _ T D $ D I F F ] did not find any significant association between the pulmonary artery embolic burden assessed with the Qanadli index and short-term death due to PE. Apfaltrer et al. 17 while in our study it was 41.20 AE 12.08 years. These differences in age and severity of pulmonary obstruction reflect differences in the patient characteristics among various studies. Moreover we have not addressed inter and intra observer variability. The outcomes studied in various reports were different. Most of the studies did not exclude pulmonary co-morbidities which can influence outcomes. In patients with associated pulmonary disease, less pulmonary vascular obstruction is required to achieve a similar degree of physiologic impairment.
38
[ 1 8 4 _ T D $ D I F F ] Discordance among studies regarding embolic burden may be due to difference in patient's characteristics and definition of outcomes. Analysis of the accuracy of CTPA parameters in detecting adverse events is limited by heterogeneity across studies. This highlights the need for large prospective multicentre study to evaluate the prognostic role of CTPA parameters.
We found that Qanadli index is better predictor of adverse events than NT-proBNP and RVEDD, RV/LV ratio on echocardiogram and CTPA as indicated by greater AUC. Qanadli index has more specificity and positive predictive value than NT-proBNP in identifying adverse events but not sufficient high enough to be used alone. The results of this study may have important clinical implications. Qanadli index and NT-proBNP are better predictors of adverse events than echocardiography. A simple and rapid bedside measurement of NT-pro-BNP might facilitate triage of acute PE patients. As CT is best diagnostic imaging modality and simultaneous assessment of the cardiac chambers is a quick and practical means of evaluating for right heart dysfunction. CTPA can be useful as both diagnostic and prognostic tool in patients. Qanadli index and NT-proBNP will help to identify subset of acute PE patients with RV dysfunction, who are hemodynamically stable at admission, worsens during hospital stay even after initiation of anticoagulation. Identification of this sub group shall help in early recognition [ 
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